|
|
Volumn 5, Issue 10, 2008, Pages 533-
|
|
The ethics of phase I trials of biologic agents
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADALIMUMAB;
BIOLOGICAL PRODUCT;
INFLIXIMAB;
ANTIBODY PRODUCTION;
CLINICAL TRIAL;
CROHN DISEASE;
DELAYED HYPERSENSITIVITY;
DRUG APPROVAL;
DRUG EFFICACY;
DRUG RESEARCH;
DRUG SCREENING;
EDITORIAL;
ENTERITIS;
HUMAN;
INFORMED CONSENT;
NONHUMAN;
PATIENT PARTICIPATION;
PATIENT SELECTION;
PRIORITY JOURNAL;
RESEARCH ETHICS;
BIOLOGICAL THERAPY;
CLINICAL TRIALS, PHASE I AS TOPIC;
GASTROINTESTINAL DISEASES;
HUMANS;
LIVER DISEASES;
|
|
EID: 53749097377
PISSN: 17434378
EISSN: 17434386
Source Type: Journal
DOI: 10.1038/ncpgasthep1259 Document Type: Editorial |
|
Times cited : (5)
|
|
References (0)
|
